bioRxiv · 10.1101/2024.10.29.619904
Antibiotic lethality dictates mycobacterial infection outcomes
Abstract
Antibiotic development and treatment focus on bacterial growth inhibition, often with limited success. Here, we introduce Antimicrobial Single-Cell Testing (ASCT), an advanced imaging strategy to assess bacterial killing in real-time. By tracking 140 million bacteria and generating over 20,000 in vitro time-kill curves, we can predict Mycobacterium tuberculosis treatment outcomes in mice and humans and link strain-specific survival (drug tolerance) in Mycobacterium abscessus to clinical responses. Using ASCT, we reveal drug tolerance as a distinct genetically encoded bacterial trait conserved across drugs with similar targets and, via genome-wide associations, uncover molecular mechanisms that govern bacterial killing. This study establishes the technical framework and in vivo validation for large-scale bacterial killing assessments to advance our understanding of bacterial survival, antibiotic development and clinical decision-making.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jovanovic, A., Bright, F. K., Sadeghi, A., Wicki, B., Muniz, S. E. C., Toprak, S., Sauteur, L., Rodoni, A., Wust, A., Lupien, A., Borrell, S., Grogono, D. M., Wheeler, N., Dehio, P., Nemeth, J., Pargger, H., Thomson, R., Bell, S. C., Gagneux, S., Bryant, J. M., Peng, T., Diacon, A., Floto, R. A., Abanto, M., Boeck, L.. 2024-10-29. Antibiotic lethality dictates mycobacterial infection outcomes. https://doi.org/10.1101/2024.10.29.619904
Cite the original work for its findings. Save a collection to share your selection of sources.